Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
30.25
+1.45 (5.03%)
At close: Jun 25, 2026, 4:00 PM EDT
30.50
+0.25 (0.83%)
After-hours: Jun 25, 2026, 7:48 PM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.8 billion as of June 25, 2026. Its market cap has increased by 258.59% in one year.
Market Cap
3.80B
Enterprise Value
3.16B
1-Year Change
258.59%
Ranking
Category
Stock Price
$30.25
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.80B, an increase of 437.30%. That is a compound annual growth rate of 22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 3.80B | 47.87% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.94B |
| Relay Therapeutics | 3.93B |
| Catalyst Pharmaceuticals | 3.85B |
| Crinetics Pharmaceuticals | 3.81B |
| NewAmsterdam Pharma Company | 3.81B |
| Telix Pharmaceuticals | 3.68B |
| Parabilis Medicines | 3.48B |
| Arcutis Biotherapeutics | 3.42B |